Article Details
Retrieved on: 2021-04-10 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
With 19.2 months follow-up, a significant PFS benefit with copanlisib versus placebo, respectively, was seen across most NHL subtypes: Follicular ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here